Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlternative Liq Regulatory News (ALF)

Share Price Information for Alternative Liq (ALF)

Share Price is delayed by 15 minutes
Get Live Data
0.0215    0.00 (0.00%)
Bid:
0.003
Ask:
0.04
Spread: 0.037 (1,233.333%)
Market Cap: $3.14m
ALF Live PriceLast checked at - London Stock Exchange

Intraday Alternative Liq Share Chart

Portfolio Update

3 Jul 2025 09:45

RNS Number : 6117P
Alternative Liquidity Fund Limited
03 July 2025
 

ALTERNATIVE LIQUIDITY FUND LIMITED

Registered in Guernsey - Number 60552

LEI NUMBER 213800R5CHD76J3LU713

 

Registered Office:

1 Royal Plaza, Royal Avenue,

St Peter Port, Guernsey, GY1 2HL

 

3 July 2025

PORTFOLIO UPDATE

The Board and the Investment Adviser have received a positive update from Vision Brazil with regard to the FCVS RJ Fund. As previously communicated in the 2024 interim accounts and recent fact sheets, Vision and their advisers have been negotiating the FCVS RJ credits through the government system and have achieved some success. Over 80% of the credits in the portfolio which were approved by Caixa and officially handed over to the Treasury have now been novated. Having signed a novation contract with the Treasury, the related cash and bonds have been deposited into the V3 FIDC securities account.

A further tranche remains under review by the Treasury, and this may transition through to novation in the next several months.

With respect to the first novated tranche, Vision will now work with tax lawyers, service providers and the independent directors to determine and execute the following:

- the fiscal deductions that need to be settled in Brazil;

- the distribution waterfall approval;

- directors' resolution approval;

- execution of FIDC amortization;

- execution of FX transaction;

- transfer of funds among intermediate offshore vehicles; and

- sending notice of redemption to the Cayman administrator (Suntera); and

- Finally the joint authorization from Vision and Suntera for payment on behalf of each investor.

Vision estimates that the above steps will take approximately one month to complete. With respect to the waterfall of payments, we expect the V Invest RJ Loan to be settled in full first (ALF's share being circa US$2.67mlm), followed by the repayment of the recent US$3mln recapitalisation loan. The balance will then be distributed to all shareholders.

ALF owns 21.5% of the Vision RJ Fund and using an approximate estimate for the expected deductions that are listed above, we anticipate that ALF should receive a figure roughly equivalent to Vision's March 31, NAV for the RJ Fund. This was US$14.88mln.

We would like to re-iterate that this recovery estimate is an indicative guideline only. At this point we do not have accurate data with respect to the deductions listed above. Consequently, the recovery number could increase or decrease.

Based on the estimated timeline received from Vision, it is possible that this exercise could be completed prior to the end of August, however, accurate timing is difficult to ascertain at this point.

Once funds have been received, the Board will determine the appropriate amount of cash to be distributed through redeemable B shares. The Board will also take soundings from shareholders with a view to making recommendations with respect to the remaining assets in the portfolio.

Enquiries

 

Tim Gardner, Hindsight Solutions Limited

Tel. +44 7917 630 460

Email: timgardner@hindsightsolutions.co.uk

Website:   https://alternativeliquidityfund.com/

 

 

Apex Fund and Corporate Services (Guernsey) Limited

Telephone: +44 (0) 20 3530 3111

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUFIFVTDEIVIIE
Date   Source Headline
29th Apr 20264:32 pmRNSAnnual Report and Audited Financial Statements
5th Mar 20264:00 pmRNSNet Asset Value and Factsheet
19th Dec 20251:30 pmRNSNet Asset Value and Factsheet
11th Dec 20255:15 pmRNSResult of AGM
21st Nov 20254:14 pmRNSNotice of AGM
9th Oct 20254:30 pmRNSNet Asset Value, Fund Update and Factsheet
22nd Sep 20255:20 pmRNSReceipt of Funds and Return of Capital
10th Jul 20259:00 amRNSShareholder Update
8th Jul 202511:05 amRNSHolding(s) in Company
8th Jul 202511:04 amRNSHolding(s) in Company
3rd Jul 20259:45 amRNSPortfolio Update
24th Jun 20254:00 pmRNSHolding(s) in Company
19th Jun 20259:00 amRNSNet Asset Value and Factsheet
5th Jun 20253:03 pmRNSHolding(s) in Company
5th Jun 202510:00 amRNSHolding(s) in Company
23rd May 20253:04 pmRNSHolding(s) in Company
13th May 20253:37 pmRNSHolding(s) in Company
21st Mar 20254:50 pmRNSHalf-year Report
17th Mar 20259:30 amRNSNet Asset Value and Factsheet
3rd Feb 20257:00 amRNSAmalgamation of Administrator
9th Dec 20241:00 pmRNSPortfolio Update
4th Dec 20242:49 pmRNSResult of AGM
2nd Dec 20245:00 pmRNSNet Asset Value and Factsheet
22nd Nov 20244:16 pmRNSNotice of AGM
24th Oct 20247:00 amRNSAnnual Financial Report
25th Sep 202412:00 pmRNSNet Asset Value and Factsheet
30th Aug 20247:00 amRNSTotal Voting Rights
16th Aug 202411:44 amRNSCancellation of Shares
26th Jul 20249:36 amRNSPortfolio Update
21st Jun 20241:22 pmRNSFinal Net Asset Value & Factsheet
20th Mar 20241:55 pmRNSHalf-year Report
27th Feb 20242:00 pmRNSNet Asset Value and Factsheet
6th Dec 20232:03 pmRNSResult of AGM
27th Nov 20232:00 pmRNSNet Asset Value and Factsheet
21st Nov 20231:45 pmRNSNotice of AGM
26th Oct 20238:36 amRNSAnnual Financial Report
29th Sep 20237:00 amRNSTotal Voting Rights
8th Sep 20237:00 amRNSCancellation of Shares
30th Aug 20232:00 pmRNSPortfolio Update
29th Aug 202310:30 amRNSNet Asset Value and Factsheet
19th Jun 202311:30 amRNSFinal Net Asset Value & Factsheet
23rd Mar 20237:00 amRNSHalf-year Report
20th Mar 20239:05 amRNSSecond Price Monitoring Extn
20th Mar 20239:00 amRNSPrice Monitoring Extension
23rd Feb 202312:00 pmRNSNet Asset Value and Factsheet
14th Feb 20234:40 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
14th Feb 202311:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.